New York Presbyterian Hospital/Columbia University Medical Center -
Locations
180 Fort Washington Avenue
Harkness Pavilion 11th Floor, Room 1133
New York, NY 10032
Transplant Summary
From January 1, 2022 to December 31st, 2023
Program type: Adult, Pediatric
21
Marrow
58
PBSC
0
Cord Blood
80
Autologous*
*PBSC or marrow
Overview
The Blood and Marrow Transplantation Program at the Morgan Stanley Children's Hospital of New York-Presbyterian is an international transplant center, specializing in the treatment of children and young adults. We are a FACT, COG, NMDP-accredited transplant program. The Adult Blood and Marrow transplant program at New York Presbyterian is accredited by the NMDP and FACT accredited for autologous and allogeneic transplantation. We have 18 bed state of the art inpatient unit which opened in April 2014. We specialize in treatment of adults with Multiple Myeloma, Amyloidosis, Leukemia, Lymphoma, Sickle Cell disease, and various other blood diseases.This center has been performing allogeneic transplants since 1997 and has been an NMDP transplant center since May 2002.
Attending physicians
Adult - Divaya Bhutani, Rajshekhar Chakraborty, Suzanne Lentzsch, Markus Mapara, Pawel Muranski, Ran Reshef, Tamna Wangjam, Olatundun Williams
Pediatric - Monica Bhatia, James. H Garvin, Diane George, Prakash SatwaniTransplants performed
Marrow/PBSC and single cordCord blood transplants
Pediatric onlyOther programs and services
The pediatric program has access to 3 local Ronald McDonald housing, a comprehensive center of wellness including massage, acupuncture, aromatherapy as well as other complimentary medicine treatments. There is a sibling program offering playroom hours only for siblings of patients. We have talented and well trained art therapists, music therapists, and child life therapists to assist your child through treatment.
The adult program has a dedicated psychiatrist to assist patients through their continuum of care. In addition, we offer music and art therapy individually or in a group setting; individual or group meditation sessions; access to our fitness center for family members; and access to Hope Lodge, a lodging facility for patients traveling for treatments. Hotel accommodation are also available in the vicinity.Patient survival information for this center
Morgan Stanley Children's Hospital of New York
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 42 patients.The actual 1-year survival of these patients is 76.2%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 73.9% and 94.2%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.New York Presbyterian Hospital/Columbia University Medical Center
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 51 patients.The actual 1-year survival of these patients is 62.7%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.1% and 86.7%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
106
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow4PBSC19Cord blood0Total23Unrelated donorMarrow0PBSC18Cord blood0Total18Total allogeneicMarrow4PBSC37Cord blood0Total41AutologousMarrowBoth marrow & PBSC 65PBSC—Cord blood—Total65Total combinedMarrowBoth marrow & PBSC 106PBSC—Cord blood0Total106Total pediatric transplants
53
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow7PBSC16Cord blood0Total23Unrelated donorMarrow10PBSC5Cord blood0Total15Total allogeneicMarrow17PBSC21Cord blood0Total38AutologousMarrowBoth marrow & PBSC 15PBSC—Cord blood—Total15Total combinedMarrowBoth marrow & PBSC 53PBSC—Cord blood0Total53All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-181719-441545-64465+6Total42Unrelated 0-181519-44545-64465+9Total33Autologous 0-181419-44945-642665+30Total79Total 0-184619-442945-643465+45Total154Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Children's Hospital of New York
3959 Broadway New York, NY 10032 Phone:212-305-8443 For more information about this program: http://Columbiapedscancer.org (Opens in a new tab)Staff
Program Director:Monica Bhatia, MDProgram Coordinator:Danielle Dietzen, CPNPPatient Eligibility
Children- Allogeneic and Autologous transplant recipients
- 2 years after transplant.
- Patients who were transplanted as a child at this center with no upper age limit
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program if they are under age 22